JOHNSON & JOHNSON RECEIVES FDA APPROVAL FOR TRUFILL N‑BCA LIQUID EMBOLIC SYSTEM FOR THE TREATMENT OF SYMPTOMATIC CHRONIC SUBDURAL HEMATOMA

Reuters · 2d ago

Please log in to view news